In the context of cSCC carcinogenesis, IL-17 signaling in keratinocytes has been shown to promote sustained activation of the IL-17-dependent RAF4-ERK5 axis, leading to keratinocyte proliferation and tumor formation [20]. The gene discussed is IL17A; the disease is neoplasm.